Clinical trials

  • TEPRENONE (teprenone) for Postoperative atrial fibrillation
  • AVALOTCAGENE ONTAPARVOVEC for Ornithine transcarbamylase deficiency | Late-onset ornithine transcarbamylase deficiency
  • Osimertinib for Non-small cell lung cancer (EGFR-mutated, locally advanced or metastatic)
  • NALTREXONE HYDROCHLORIDE for Compulsive sexual behaviour disorder
  • Venetoclax for Chronic lymphocytic leukemia (relapsed/refractory)
  • ROGINOLISIB for Uveal melanoma | Ocular melanoma (advanced/metastatic)
  • EXEMESTANE for Luminal A breast cancer | Hormone receptor-positive (HR+) HER2-negative breast cancer
  • CANNABIDIOL for Irritable bowel syndrome with diarrhea (IBS-D)
  • CAPECITABINE for Pseudomyxoma peritonei
  • RITUXIMAB for Primary central nervous system diffuse large B-cell lymphoma (PCNSL)
  • Leriglitazone for Rett syndrome
  • VO659 for Spinocerebellar ataxia type 1 | Spinocerebellar ataxia type 3 | Huntington's disease